CompoAtlas

Arco Pharma Mydolam

Natural health product licensed in Canada

Other names
Arco Pharma Mylogesic, Arco Pharma Repagesic
Licence holder
Arco Pharma Canada Inc.
NPN or DIN-HM
80063459
Status
Inactive licence
Licence date
19 August 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zingiber officinale

Source : Rhizome

Extraction ratio : 4:1

Dry plant equivalent : 60 milligramme

15 milligrammeNot calculated
Curcuma longa

Source : Rhizome

400 milligrammeNot calculated
Ecorce de saule

Source : Salix alba

Potency : 0 0.5-1% total salicin (after hydrolysis)

15 milligrammeNot calculated
Medicago sativa

Source : Parties aériennes

2,750 milligrammeNot calculated

Non-medicinal ingredients

Hydroxypropyl methyl cellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Turmeric is Traditionally used in Herbal Medicine as an anti-inflammatory to help relieve joint pain. Willow bark is traditionally used in Herbal Medicine for the relief of minor joint pain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80063459

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line